Research and Markets: Dendritic Cells: Targets for Immunotherapy

Dublin - Research and Markets (http://www.researchandmarkets.com/reports/c22363) has announced the addition of Dendritic Cells: Targets for Immunotherapy to their offering

The report 'Dendritic Cells: Targets for Immunotherapy Report' outlines the fundamentals of dendritic cell biology, highlighting the specific functions of these cells that make them important to the success of any cell-mediated immunotherapy. The report describes diseases that have potential for treatment with dendritic cell-based therapies, and focuses on the potential market for new, effective treatments. Also included is a discussion of dendritic cell therapies in development, outlining the data published thus far, and the potential for their success.

The field of cell therapy is in its infancy. Targeting dendritic cells is important for the success of many forms of immunotherapy and as such the understanding of dendritic cell biology and the design of early drug candidates is important for the development of successful immunotherapy programs. Dendritic cells have been identified as critical components of many vaccine programs, but much of the information about these cells remains in the highly technical scientific literature. Dendritic cell based therapies have potential application across a wide variety of diseases, ranging from infectious diseases such as HIV to cancer and inflammatory disease. As such, the market potential for a successful treatment is considerable, with each approach being applicable across many diseases with only minor modifications in design.

Market opportunities include:

- Developing effective therapeutic vaccines through the selective manipulation of dendritic cell activity.
- Developing novel approaches to the management of autoimmune disease through modulation of dendritic cell activity.
- Targeting underserved markets through the development of novel therapies that utilize the immune system to prevent and treat disease.

Questions answered include:

- What are the potential markets for dendritic cell based therapy?
- What are the limitations of therapeutic vaccines for infectious disease?
- What are the technical challenges that remain to be solved for the development of effective dendritic cell based therapies?
- What are the advantages and disadvantages of various methods for preparing dendritic cells for therapeutic applications?
- How will increased understanding about dendritic cell biology impact the treatment of disease?

Company Profiles

-Aastrom Biosciences
-Argos Therapeutics
-Biomira
-Bioniche Life Sciences
-BioVex
-Coley Pharmaceutical Group
-Corixa
-Dendreon
-Igeneon
-Immuno-Designed Molecules
-Introgen Therapeutics
-Stressgen Biotechnologies
-Vasogen

For more information visit http://www.researchandmarkets.com/reports/c22363

Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets.com
Fax: +353 1 4100 980